Literature DB >> 14710970

The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I).

M Deepa1, R Pradeepa, M Rema, Anjana Mohan, R Deepa, S Shanthirani, V Mohan.   

Abstract

The report of World Health Organization (WHO) shows that India tops the world with the largest number of diabetic subjects. This increase is attributed to the rapid epidemiological transition accompanied by urbanization, which is occurring in India. There is very little data regarding the influence of affluence on the prevalence of diabetes and its complications particularly retinopathy in the Indian population. Furthermore, there are very few studies comparing the urban/rural prevalence of diabetes and its complications. The Chennai Urban Rural Epidemiology Study (CURES) is designed to answer the above questions. CURES is initially planned as a cross-sectional study to evolve later into a longitudinal study. Subjects for the urban component of the CURES have been recruited from within the corporation limits of Chennai City. Chennai (formerly Madras), the largest city in Southern India and the fourth largest in India has been divided into 10 zones and 155 wards. 46 wards were selected by a systematic random sampling method to represent the whole of Chennai. Twenty thousand and one individuals were recruited for the study, this number being derived based on a sample size calculation. The study has three phases. Phase one is a door to door survey which includes a questionnaire, anthropometric, fasting capillary blood glucose and blood pressure measurements. Phase two focussed on the prevalence of diabetic complications particularly retinopathy using standardized techniques like retinal photography etc. Diabetic subjects identified in phase one and age and sex matched non-diabetic subjects will participate in these studies. Phase three will include more detailed studies like clinical, biochemical and vascular studies on a sub-sample of the study subjects selected on a stratified basis from phase one. CURES is perhaps one of the largest systematic population based studies to be done in India in the field of diabetes and its complications like retinopathy, nephropathy and neuropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14710970

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  86 in total

1.  Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Authors:  Nathella P Kumar; Rathinam Sridhar; Dina Nair; Vaithilingam V Banurekha; Thomas B Nutman; Subash Babu
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

2.  Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.

Authors:  Abhijit Shiny; Bhaskaran Regin; Venketesan Balachandar; Kuppan Gokulakrishnan; Viswanathan Mohan; Subash Babu; Muthuswamy Balasubramanyam
Journal:  Cytokine       Date:  2013-09-06       Impact factor: 3.861

3.  Metabolic Consequences of Concomitant Strongyloides stercoralis Infection in Patients With Type 2 Diabetes Mellitus.

Authors:  Anuradha Rajamanickam; Saravanan Munisankar; Yukthi Bhootra; Chandrakumar Dolla; Kannan Thiruvengadam; Thomas B Nutman; Subash Babu
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

4.  High sensitivity C-reactive protein, tumor necrosis factor-α, interleukin-6, and vascular cell adhesion molecule-1 levels in Asian Indians with metabolic syndrome and insulin resistance (CURES-105).

Authors:  Karunakaran Indulekha; Jayagopi Surendar; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

5.  Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Authors:  Bruno B Andrade; Nathella Pavan Kumar; Rathinam Sridhar; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Alan Sher; Subash Babu
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

6.  Lack of association of PTPN1 gene polymorphisms with type 2 diabetes in south Indians.

Authors:  Dhanasekaran Bodhini; Venkatesan Radha; Saurabh Ghosh; Partha P Majumder; Viswanathan Mohan
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

7.  Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).

Authors:  Vivekanandhan Aravindhan; Viswanathan Mohan; Jayagopi Surendar; Maradana Muralidhara Rao; Nathella Pavankumar; Mohan Deepa; Ramanujam Rajagopalan; Vasanthapuram Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

8.  Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups.

Authors:  Dirk L Christensen; Daniel R Witte; Lydia Kaduka; Marit E Jørgensen; Knut Borch-Johnsen; Viswanathan Mohan; Jonathan E Shaw; Adam G Tabák; Dorte Vistisen
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 19.112

9.  Prevalence of depression in a large urban South Indian population--the Chennai Urban Rural Epidemiology Study (CURES-70).

Authors:  Subramani Poongothai; Rajendra Pradeepa; Anbhazhagan Ganesan; Viswanathan Mohan
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

10.  A1C cut points to define various glucose intolerance groups in Asian Indians.

Authors:  Viswanathan Mohan; Venkataraman Vijayachandrika; Kuppan Gokulakrishnan; Ranjit Mohan Anjana; Anbazhagan Ganesan; Mary Beth Weber; K M Venkat Narayan
Journal:  Diabetes Care       Date:  2009-11-10       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.